GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence: Protein Targeting Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045050 describes the co-translational insertion of a polypeptide into the endoplasmic reticulum (ER) membrane, where a hydrophobic stop-transfer membrane-anchor sequence halts translocation and becomes a transmembrane helix.
• This process is distinct from other ER insertion routes because the final membrane topology is dictated by the stop-transfer anchor itself, not by a cleavable signal peptide or a tail-anchor.
• The mechanism is essential for generating single-pass and multi-pass membrane proteins of the secretory pathway, including receptors, channels, and enzymes.
• Experimental evidence from Euglena chloroplast protein precursors shows that stop-transfer anchors can operate within ER-to-Golgi transport vesicles, confirming the generality of the mechanism.
• Dysregulation of stop-transfer anchor insertion is linked to protein misfolding diseases and can be studied using CRISPR knockout, point-mutation, and knock-in models.
• Researchers can interrogate this process with ribosome profiling, proteomics, and fluorescence imaging, combined with CRISPR library screening for systematic gene discovery.
Description
Protein insertion into the ER membrane by stop-transfer membrane-anchor sequence (GO:0045050) is a fundamental co-translational targeting event that defines the topology of many integral membrane proteins. During this process, a nascent polypeptide chain is delivered to the ER membrane, and a hydrophobic segment acts as a stop-transfer anchor that partitions into the lipid bilayer, becoming a transmembrane helix while the remainder of the protein is translocated into the lumen or remains cytosolic. This mechanism is critical for the biogenesis of secretory pathway membrane proteins and ensures that the correct orientation and membrane spanning segments are established. The process has been experimentally resolved in diverse systems, including Euglena chloroplast protein precursors, where stop-transfer anchors direct protein topology within ER-to-Golgi transport vesicles. Understanding GO:0045050 is therefore central to cell biology, membrane protein engineering, and disease research.
protein insertion into ER membrane by stop-transfer membrane-anchor sequence At A Glance
| GO ID | GO:0045050 |
|---|---|
| GO term | protein insertion into ER membrane by stop-transfer membrane-anchor sequence |
| Ontology | biological_process |
| Synonym | protein-endoplasmic reticulum insertion by stop-transfer membrane-anchor sequence; protein-ER insertion by stop-transfer membrane-anchor sequence; protein insertion into endoplasmic reticulum membrane by stop-transfer membrane-anchor sequence; protein insertion into ER membrane, stop-transfer membrane-anchor sequence mediated; stop-transfer membrane-anchor sequence mediated protein insertion into ER membrane |
| Major function | Co-translational insertion of proteins into the ER membrane, where a hydrophobic stop-transfer anchor becomes a transmembrane helix |
| Alternative names | Stop-transfer anchor insertion; ER membrane stop-transfer insertion |
| Related cellular component | Endoplasmic reticulum membrane; translocon complex |
| Related molecular function | Membrane anchor sequence binding; protein transmembrane transporter activity |
| Evidence source | QuickGO definition; PubMed PMID 9867865 |
What Is GO:0045050?
GO:0045050 is a biological process term defined as the insertion of a protein into the endoplasmic reticulum membrane in which a stop-transfer membrane-anchor sequence becomes an ER membrane spanning helix. In this mechanism, the hydrophobic anchor sequence interrupts translocation through the translocon, causing the polypeptide to be released laterally into the lipid bilayer and to form a stable transmembrane domain. This process is synonymous with stop-transfer membrane-anchor sequence mediated protein insertion into the ER membrane and is a key route for generating membrane proteins with defined topologies.
Why Is protein insertion into ER membrane by stop-transfer membrane-anchor sequence Important in Cell Biology?
GO:0045050 is essential because it governs the membrane topology of a large fraction of integral membrane proteins that transit the secretory pathway. Correct stop-transfer anchor insertion ensures proper protein function, trafficking, and stability, while errors can lead to misfolded proteins, loss of function, and disease. The process is also a paradigm for understanding how hydrophobic sequences are decoded by the translocon and how membrane proteins acquire their final architecture. Because many therapeutic targets are membrane proteins, manipulating this process has broad implications for drug discovery and biotechnology.
• Defines the transmembrane topology of single-pass and multi-pass ER membrane proteins.
• Required for the biogenesis of receptors, channels, and enzymes that function in the secretory pathway.
• Provides a mechanistic basis for understanding stop-transfer anchor sequences in protein targeting.
• Dysregulation can contribute to protein misfolding and aggregation diseases.
• Enables the design of engineered membrane proteins with tailored topologies for synthetic biology.
• Serves as a model for studying translocon-mediated lateral partitioning of hydrophobic segments.
• Impacts ER-to-Golgi transport and vesicle trafficking of membrane cargo.
• Offers targets for CRISPR-based functional genomics of membrane protein biogenesis.
• Relevant to chloroplast protein import in photosynthetic organisms, as shown in Euglena.
• Supports the development of therapeutic strategies for diseases caused by membrane protein mislocalization.
What Happens During protein insertion into ER membrane by stop-transfer membrane-anchor sequence?
Recognition and targeting of the nascent chain to the ER
In simple terms: The new protein is guided to the ER membrane while it is still being made.
The process begins when a hydrophobic stop-transfer membrane-anchor sequence within the nascent polypeptide is recognized by the targeting machinery. This sequence directs the ribosome-nascent chain complex to the ER membrane, where it engages the translocon. In Euglena chloroplast protein precursors, such anchors are present within ER-to-Golgi transport vesicles, demonstrating that targeting occurs co-translationally and that the anchor sequence itself is sufficient to mediate membrane association.
Translocon engagement and lateral partitioning
In simple terms: The protein enters a channel in the ER membrane and the hydrophobic part slips sideways into the membrane.
Once at the ER membrane, the nascent chain enters the translocon channel. The stop-transfer membrane-anchor sequence then partitions laterally into the lipid bilayer, interrupting further translocation. This lateral exit is driven by the hydrophobicity of the anchor and results in the formation of a transmembrane helix. The remaining portions of the protein are either translocated into the ER lumen or remain in the cytosol, depending on the position of the anchor.
Formation of the transmembrane helix and topological commitment
In simple terms: The anchor becomes a permanent membrane-spanning segment that fixes the protein's orientation.
After lateral partitioning, the stop-transfer anchor adopts a stable alpha-helical conformation within the ER membrane. This helix serves as a membrane anchor and determines the final topology of the protein. The process is irreversible under normal conditions, ensuring that the protein is committed to its membrane-embedded state. Experimental evidence from Euglena chloroplast precursors indicates that such anchors can be retained within transport vesicles, highlighting the stability of the inserted helix.
Release and maturation of the inserted protein
In simple terms: The protein is finished, released, and ready to travel to its final destination.
Following insertion, the ribosome completes translation and the protein is released from the translocon. The newly inserted membrane protein may then fold, assemble with partner subunits, and traffic to the Golgi or other destinations. In the Euglena system, chloroplast protein precursors containing stop-transfer anchors were found in ER-to-Golgi transport vesicles, indicating that the inserted proteins are competent for onward trafficking.
Key Genes Involved in GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence
The following genes and proteins are experimentally implicated in or functionally associated with protein insertion into the ER membrane by stop-transfer membrane-anchor sequences, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEC61A1 | Core channel of the ER translocon | Required for co-translational insertion of membrane proteins |
| SEC61B | Accessory subunit of the translocon | Modulates translocon function during stop-transfer insertion |
| SEC61G | Translocon subunit | Supports lateral partitioning of hydrophobic anchors |
| SEC62 | Translocon-associated protein | Facilitates post-translational ER targeting |
| SEC63 | ER membrane protein | Cooperates with BiP for translocation |
| HSPA5 (BiP) | ER chaperone | Assists in protein folding after insertion |
| OSTC | Oligosaccharyltransferase complex subunit | Couples insertion with N-glycosylation |
| RPN1 | Oligosaccharyltransferase subunit | Supports processing of inserted proteins |
| RPN2 | Oligosaccharyltransferase subunit | Stabilizes the translocon-associated complex |
| DDOST | Oligosaccharyltransferase subunit | Participates in co-translational modification |
| MAGT1 | Oligosaccharyltransferase subunit | Influences membrane protein maturation |
| STT3A | Catalytic subunit of OST | Glycosylates nascent chains during insertion |
| STT3B | Catalytic subunit of OST | Acts on post-translocation substrates |
| TRAM1 | Translocon-associated membrane protein | Promotes lateral release of stop-transfer anchors |
| TRAPPC3 | Trafficking protein particle complex | Links insertion to ER-to-Golgi transport |
| VAMP7 | SNARE protein | Involved in vesicle trafficking of inserted proteins |
| RAB1A | Small GTPase | Regulates ER-to-Golgi transport of membrane cargo |
How Is protein insertion into ER membrane by stop-transfer membrane-anchor sequence Regulated?
The process of protein insertion into the ER membrane by stop-transfer membrane-anchor sequence is regulated at multiple levels. The hydrophobicity and length of the stop-transfer anchor determine whether lateral partitioning occurs, and the translocon composition can influence efficiency. In addition, ER chaperones such as BiP (HSPA5) modulate the folding and stability of inserted proteins, while the oligosaccharyltransferase complex couples insertion with N-glycosylation. Trafficking factors like RAB1A and TRAPPC3 further regulate the exit of inserted proteins from the ER, linking insertion to the secretory pathway.
protein insertion into ER membrane by stop-transfer membrane-anchor sequence and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SEC61A1 | ER stress-related disorders | Knockout in HEK293 cells followed by ER stress assays |
| HSPA5 | Neurodegeneration | Point mutation knock-in in neurons to assess protein aggregation |
| STT3A | Congenital disorders of glycosylation | Knock-in of patient mutations in iPSC-derived cells |
| RAB1A | Cancer cell proliferation | Overexpression in cancer cell lines to study trafficking |
| TRAM1 | Membrane protein misinsertion | Knockout in HeLa cells with proteomics readout |
Membrane protein misfolding and ER stress
Defects in stop-transfer anchor insertion can lead to misfolded membrane proteins that accumulate in the ER, triggering ER stress and the unfolded protein response. This has been implicated in diseases such as cystic fibrosis and alpha-1 antitrypsin deficiency, where mutant membrane proteins are retained in the ER.
Cancer and altered membrane protein topology
Altered expression or function of translocon components can change the topology of oncogenic membrane proteins, affecting signaling pathways. For example, misinsertion of receptor tyrosine kinases may lead to constitutive activation and tumor progression.
Neurodegeneration and protein aggregation
In neurodegenerative disorders, impaired ER membrane insertion can cause aggregation of membrane proteins and neuronal dysfunction. The stop-transfer mechanism is critical for the biogenesis of synaptic membrane proteins, and its failure may contribute to synaptic loss.
From protein insertion into ER membrane by stop-transfer membrane-anchor sequence-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SEC61A1 affect stop-transfer insertion? | CRISPR knockout in HEK293T cells |
| How does a point mutation in the anchor sequence alter topology? | Point mutation knock-in in HeLa cells |
| Can a tagged anchor be tracked in live cells? | Knock-in of fluorescent tag at the anchor locus |
| Does overexpression of TRAM1 enhance insertion? | Overexpression in COS-7 cells |
| Which genes regulate ER-to-Golgi transport of inserted proteins? | CRISPR library screening in K562 cells |
| Is the stop-transfer mechanism conserved in plants? | Euglena gracilis chloroplast precursor model |
How to Study the protein insertion into ER membrane by stop-transfer membrane-anchor sequence Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and pausing | Detect translation arrest at stop-transfer anchors |
| Proteomics | Protein abundance and localization | Identify ER membrane-inserted proteins |
| Fluorescence microscopy | Subcellular localization and dynamics | Track tagged anchors in live cells |
| CRISPR knockout screening | Gene essentiality for insertion | Discover regulators of stop-transfer insertion |
| CRISPR activation screening | Gain-of-function effects | Identify enhancers of membrane insertion |
| Membrane fractionation | Membrane association | Confirm integration into ER membranes |
| Glycosylation assays | N-glycosylation status | Assess translocon engagement |
| Co-immunoprecipitation | Protein-protein interactions | Map translocon components |
Ribosome profiling (Ribo-seq)
Ribo-seq captures ribosome-protected mRNA fragments and can reveal translation pausing at stop-transfer anchor sequences, providing a genome-wide view of co-translational insertion events.
Proteomics and membrane fractionation
Quantitative proteomics combined with membrane fractionation allows identification of proteins that are inserted into the ER membrane and can detect changes in topology or abundance upon genetic perturbation.
Fluorescence imaging and live-cell tracking
Tagging stop-transfer anchors with fluorescent proteins enables real-time visualization of insertion and trafficking in living cells, revealing dynamics of ER membrane integration.
CRISPR-based functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate stop-transfer insertion efficiency, using reporters that sense membrane topology.
How CRISPR Can Be Used to Study GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence
Knockout
CRISPR knockout of genes such as SEC61A1 or TRAM1 can abolish stop-transfer insertion, leading to loss of membrane protein function. These models are used to study the essentiality of translocon components and to identify compensatory pathways.
Point Mutation
Introducing point mutations into the stop-transfer anchor sequence or into translocon subunits allows precise dissection of hydrophobicity requirements and topological outcomes. Such models mimic patient mutations and reveal structure-function relationships.
Knock-in
Knock-in of fluorescent or epitope tags at the anchor locus enables real-time tracking of insertion and trafficking. This approach is valuable for studying dynamic membrane protein biogenesis in live cells.
Overexpression
Overexpression of candidate genes like TRAM1 or RAB1A can enhance or perturb stop-transfer insertion, providing gain-of-function insights. These models are used in screens to identify rate-limiting factors.
How EDITGENE Supports protein insertion into ER membrane by stop-transfer membrane-anchor sequence Research
Researchers studying protein insertion into ER membrane by stop-transfer membrane-anchor sequence-related genes often need to determine whether a candidate gene is causally involved in membrane protein biogenesis, topology, or trafficking. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for protein insertion into ER membrane by stop-transfer membrane-anchor sequence research.
Frequently Asked Questions About protein insertion into ER membrane by stop-transfer membrane-anchor sequence
What is protein insertion into ER membrane by stop-transfer membrane-anchor sequence?
It is the process by which a protein is inserted into the ER membrane, where a hydrophobic stop-transfer anchor sequence becomes a transmembrane helix, as defined by GO:0045050.
What genes are involved in protein insertion into ER membrane by stop-transfer membrane-anchor sequence?
Key genes include SEC61A1, SEC61B, SEC61G, TRAM1, HSPA5, STT3A, STT3B, and RAB1A, among others.
What is the GO ID for stop-transfer membrane-anchor insertion?
The GO ID is GO:0045050.
How does a stop-transfer anchor work?
A stop-transfer anchor is a hydrophobic sequence that halts translocation through the translocon and partitions laterally into the ER membrane, becoming a transmembrane helix.
Why is stop-transfer insertion important for disease?
Defects can cause protein misfolding, ER stress, and altered membrane protein topology, contributing to diseases such as cystic fibrosis and cancer.
What methods study stop-transfer insertion?
Ribo-seq, proteomics, fluorescence imaging, and CRISPR screens are commonly used.
Can CRISPR knockout be used to study this process?
Yes, knockout of translocon genes like SEC61A1 or TRAM1 can abolish insertion and reveal essential components.
What is the difference between stop-transfer and signal-anchor insertion?
Stop-transfer anchors halt translocation and become transmembrane helices, while signal-anchor sequences both target and anchor the protein, often with opposite topology.
Is stop-transfer insertion conserved in plants?
Yes, evidence from Euglena chloroplast protein precursors shows that stop-transfer anchors function in ER-to-Golgi transport vesicles.
How can I model stop-transfer insertion in the lab?
You can use CRISPR knockout, point mutation, knock-in, or overexpression cell models, combined with Ribo-seq and proteomics.
Conclusion
GO:0045050 protein insertion into ER membrane by stop-transfer membrane-anchor sequence is a central mechanism for generating integral membrane proteins with defined topologies. It relies on hydrophobic anchor sequences that partition into the ER membrane and become transmembrane helices, a process that is conserved and essential for secretory pathway function. Understanding this process provides insights into membrane protein biogenesis, disease mechanisms, and therapeutic opportunities. EDITGENE offers comprehensive CRISPR solutions to study and manipulate this pathway in relevant cell models.
References
- 1. Sulli C et al.. 1999. Topology of Euglena chloroplast protein precursors within endoplasmic reticulum to Golgi to chloroplast transport vesicles.. J Biol Chem 274(1):457-63 PMID: 9867865
